# CONTRAFECT Corp: Form D filings

CONTRAFECT Corp, a biotechnology company in Yonkers, NY, filed 6 Form D notices with the SEC between 2010 and 2015. The latest, on June 25, 2015, reports $20 million sold of a $20 million offering to 9 investors.

Find out what CONTRAFECT Corp does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20CONTRAFECT%20Corp%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=CONTRAFECT%20Corp&page=%2Fdata%2Fform-d%2Fcompany%2Fcontrafect-corp-1478069)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20CONTRAFECT%20Corp%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=CONTRAFECT%20Corp&page=%2Fdata%2Fform-d%2Fcompany%2Fcontrafect-corp-1478069)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in New York](https://specstream.ai/data/form-d/state/new-york): 4,357 rows, by operating companies, filed since November 1, 2024, $123.57, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/new-york
- [Form D filings in Biotechnology](https://specstream.ai/data/form-d/industry/biotechnology): 1,568 rows, by operating companies, filed since November 1, 2024, $78.40, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/biotechnology

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 28 WELLS AVENUE, 3RD FLOOR, Yonkers, NY, 10701
- Phone: (914) 207-2300
- Industry: Biotechnology
- Entity type: Corporation
- Incorporated in: Delaware
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(c)
- SEC identifier (CIK): 1478069

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Jun 25, 2015 | New notice | $20,000,000 | $20,000,000 | $0 | 9 | Jun 12, 2015 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1478069/000094787115000448/0000947871-15-000448-index.htm) |
| Mar 12, 2014 | New notice | Indefinite | $0 | Indefinite | 1 | Feb 24, 2014 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1478069/000094787114000142/0000947871-14-000142-index.htm) |
| Sep 4, 2013 | Amendment | $15,000,000 | $11,963,650 | $3,036,350 | 124 | Jun 18, 2013 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1478069/000146581813000007/0001465818-13-000007-index.htm) |
| Jul 1, 2013 | New notice | $10,000,000 | $9,997,650 | $2,350 | 94 | Jun 18, 2013 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1478069/000146581813000005/0001465818-13-000005-index.htm) |
| Sep 15, 2011 | New notice | $25,000,000 | $12,502,905 | $12,497,095 | 125 | Aug 31, 2011 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1478069/000114036111046045/0001140361-11-046045-index.htm) |
| Aug 23, 2010 | New notice | $10,000,000 | $4,326,603 | $5,673,397 | 6 | Aug 6, 2010 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1478069/000114036110034658/0001140361-10-034658-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Roger J. Pomerantz, Ph.D. | Director |  |
| Cary C. Sucoff | Director |  |
| Julia P. Gregory | Executive Officer, Director |  |
| Michael J. Otto, Ph.D. | Director |  |
| Michael C. Messinger | Executive Officer |  |
| Lawrence Yuan Tian, Ph.D. | Director |  |
| Sol Barer, Ph.D. | Director |  |
| David N. Low, Jr. | Director |  |
| Michael C. Wittekind, Ph.D. | Executive Officer |  |
| Natalie Yuan Bogdanos | Executive Officer |  |
| David C. Scheinberg, M.D., Ph.D. | Director |  |
| Isaac C. Blech | Director |  |
| Steven C. Gilman, Ph.D. | Director |  |

## Other biotechnology companies in New York that filed recently

- [Swep Bio, Inc.](https://specstream.ai/data/form-d/company/swep-bio-inc-2159106) $2.5 million · Oct 29, 2026
- [Hypercell Technologies Inc.](https://specstream.ai/data/form-d/company/hypercell-technologies-inc-1882357) $3 million · Oct 14, 2026
- [CAD Therapeutics, Inc.](https://specstream.ai/data/form-d/company/cad-therapeutics-inc-2157566) $4 million · Oct 2, 2026
- [Vicora, Inc.](https://specstream.ai/data/form-d/company/vicora-inc-2091847) $2.3 million · Sep 18, 2026
- [GevRx Nutraceuticals, Inc.](https://specstream.ai/data/form-d/company/gevrx-nutraceuticals-inc-2156105) $300,000 · Sep 18, 2026
- [Episteme Prognostics, Inc.](https://specstream.ai/data/form-d/company/episteme-prognostics-inc-1902402) $5.1 million · Sep 4, 2026

[Every Form D from the week of Jun 22, 2015](https://specstream.ai/data/form-d/week/2015-06-22) · [All recent filings in New York](https://specstream.ai/data/form-d/state/new-york) · [All recent Biotechnology filings](https://specstream.ai/data/form-d/industry/biotechnology)

Read from SEC EDGAR. Amount sold is what CONTRAFECT Corp reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).